90764-56-0 Usage
Uses
Used in Pharmaceutical Industry:
AIAH is used as a research compound for studying the role of ornithine decarboxylase and arginase in various biological processes and diseases. Its inhibitory properties make it a valuable tool in understanding the mechanisms of these enzymes and their potential as therapeutic targets.
Used in Cancer Research:
AIAH is used as a potential therapeutic agent in cancer research, as ornithine decarboxylase is often overexpressed in various types of cancer. By inhibiting this enzyme, AIAH may help to reduce tumor growth and progression.
Used in Neurological Disorders Research:
AIAH is used as a research tool in the study of neurological disorders, as arginase inhibition has been implicated in the regulation of nitric oxide synthesis and may have potential therapeutic effects in conditions such as neurodegeneration and stroke.
Used in Wound Healing and Tissue Repair:
AIAH is used as a research compound in the investigation of wound healing and tissue repair processes, as ornithine decarboxylase plays a role in cell proliferation and tissue regeneration. Inhibiting this enzyme with AIAH may provide insights into the mechanisms of wound healing and potential therapeutic approaches.
Check Digit Verification of cas no
The CAS Registry Mumber 90764-56-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,6 and 4 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90764-56:
(7*9)+(6*0)+(5*7)+(4*6)+(3*4)+(2*5)+(1*6)=150
150 % 10 = 0
So 90764-56-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H15IN2O3/c9-5-7(12)11-4-2-1-3-6(10)8(13)14/h6H,1-5,10H2,(H,11,12)(H,13,14)/t6-/m0/s1
90764-56-0Relevant articles and documents
Regioselective synthesis of (+)-S-2-amino-5-iodoacetamidopentanoic and (+)-S-2-amino-6-iodoacetamidohexanoic acids
Trujillo,Ceballos,Yanez,Joseph-Nathan
, p. 683 - 691 (1991)
Mild reaction conditions were developed for the preparation of the active-site-directed irreversible enzyme inhibitors (+)-S-2-amino-5-iodoacetamido-pentanoic acid and (+)-S-2-amino-6-iodoacetamido-hexanoic acid.